Organogenesis offers products across all FDA classifications.
1 report, 1 independent
Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Organogenesis offers products across all FDA classifications.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Organogenesis (United States)
company in Canton, United States
Nothing else this week.
Related events
- A product was launched in the U.S. market following FDA involvement.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- FDA and Pfizer are seeking regulatory approval for their products.
- Mylan is seeking regulatory approval from the FDA for new products and has listed its stock on the Nasdaq exchange.
- FDA approval enables commercial opportunity involving CBRE Group.
Coverage
Newest first; wire copies grouped- GlobeNewswireOrganogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results CANTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine